BIOTEST AG ST O.N./ DE0005227201 /
| 15/11/2024 17:00:02 | Chg. 0.000 | Volume | Bid15/11/2024 | Ask15/11/2024 | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 41.000EUR | 0.00% | - Turnover: - |
41.000Bid Size: 244 | 41.400Ask Size: 121 | 2.41 bill.EUR | - | 12.69 |
Assets
|
2011 IFRS in mill. EUR |
2012 IFRS in mill. EUR |
2013 IFRS in mill. EUR |
2014 IFRS in mill. EUR |
2015 IFRS in mill. EUR |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Property and Equipment | 234.9000 | 243 | 254.9000 | 282.3000 | 317.2000 | ||||||
| Intangible Assets | 62.8000 | 54.6000 | 48.1000 | 50.2000 | 44.7000 | ||||||
| Long-Term Investments | 4.7000 | .2000 | .2000 | 5.2000 | .8000 | ||||||
| Fixed Assets | 312.8000 | 314.9000 | 324 | 353.3000 | 375.9000 | ||||||
| Inventories | 153 | 184.2000 | 227 | 246 | 218.7000 | ||||||
| Accounts Receivable | 121 | 96.1000 | 118.5000 | 181.6000 | 173.9000 | ||||||
| Cash and Cash Equivalents | 83.2000 | 57.2000 | 204.4000 | 179.4000 | 53.8000 | ||||||
| Current Assets | 370 | 349 | 562.5000 | 679.3000 | 586.8000 | ||||||
| Total Assets | 682.8000 | 682.3000 | 886.5000 | 1,032.6000 | 962.7000 | ||||||
Liabilities
|
2011 IFRS in mill. EUR |
2012 IFRS in mill. EUR |
2013 IFRS in mill. EUR |
2014 IFRS in mill. EUR |
2015 IFRS in mill. EUR |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 34.7000 | 47.4000 | 51.4000 | 55.5000 | 53.1000 | ||||||
| Long-term debt | 101.3000 | 71 | 226.2000 | 325.8000 | 335.5000 | ||||||
| Liabilities to Banks | 139 | 112.4000 | 231.5000 | 331.9000 | 344.6000 | ||||||
| Provisions | 43.2000 | 35.6000 | 47.7000 | 49.8000 | 46.1000 | ||||||
| Liabilities | 336.1000 | 312.9000 | 425.8000 | 552.4000 | 550.4000 | ||||||
| Share Capital | 30 | 30 | 33.8000 | 33.8000 | 39.6000 | ||||||
| Total Equity | 346.6000 | 369.3000 | 460.6000 | 480.1000 | 412.2000 | ||||||
| Minority Interests | .1000 | .1000 | .1000 | .1000 | .1000 | ||||||
| Total liabilities equity | 682.8000 | 682.3000 | 886.5000 | 1,032.6000 | 962.7000 | ||||||
Income Statement
|
2011 IFRS in mill. EUR |
2012 IFRS in mill. EUR |
2013 IFRS in mill. EUR |
2014 IFRS in mill. EUR |
2015 IFRS in mill. EUR |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 422 | 440 | 500.8000 | 582 | 589.6000 | ||||||
| Depreciation (total) | - | - | - | - | - | ||||||
| Operating Result | 41.6000 | 44.7000 | 53.8000 | 53.4000 | -71.8000 | ||||||
| Interest Income | -13.5000 | -9.2000 | -7 | -6.5000 | -4.5000 | ||||||
| Income Before Taxes | 28.6000 | 36.5000 | 47.8000 | 46.9000 | -74.3000 | ||||||
| Income Taxes | 9.9000 | 13.4000 | 15.8000 | 27.7000 | 8.2000 | ||||||
| Minority Interests Profit | -1.8000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | ||||||
| Net Income | 46.4000 | 33.4000 | 32 | 19.2000 | -82.5000 | ||||||
Per Share
Cash Flow
|
2011 IFRS in mill. EUR |
2012 IFRS in mill. EUR |
2013 IFRS in mill. EUR |
2014 IFRS in mill. EUR |
2015 IFRS in mill. EUR |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow from Operating Activities | 72.3000 | 34.7000 | -7.2000 | -11.4000 | 38.1000 | ||||||
| Cash Flow from Investing Activities | 22 | -29.3000 | -32.3000 | -102.4000 | -160.1000 | ||||||
| Cash Flow from Financing | -30.7000 | -31.4000 | 186.9000 | 87.4000 | -4.6000 | ||||||
| Decrease / Increase in Cash | 63.6000 | -26 | 147.4000 | -26.4000 | -126.6000 | ||||||
| Employees | 1,774 | 1,870 | 2,160 | 2,332 | 2,443 | ||||||
